atomoxetine hydrochloride has been researched along with Callous-Unemotional Traits in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Benarous, X; Cohen, D; Consoli, A; Ferrafiat, V; Gérardin, P; Guilé, JM; Zammit, J | 1 |
| Alegría, AA; Brinson, H; Rubia, K | 1 |
| Gardner, D; Gorman, DA; Hirsch, L; Pringsheim, T | 1 |
| Dopheide, JA; Pliszka, SR | 1 |
| Bullinger, M; Dittmann, RW; Helsberg, K; Lehmann, M; Ravens-Sieberer, U; Schacht, A; Schneider-Fresenius, C; Wehmeier, PM | 1 |
| Dittmann, RW; Helsberg, K; Lehmann, M; Lehmkuhl, G; Schacht, A; Schneider-Fresenius, C; Wehmeier, PM | 1 |
| Banaschewski, T; Dittmann, RW; Kipp, L; Schacht, A; Wehmeier, PM | 1 |
| Ivanov, I; Newcorn, JH | 1 |
3 review(s) available for atomoxetine hydrochloride and Callous-Unemotional Traits
| Article | Year |
|---|---|
Brain abnormalities in attention-deficit hyperactivity disorder: a review.
Topics: Adolescent; Adult; Atomoxetine Hydrochloride; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Brain; Brain Mapping; Central Nervous System Stimulants; Child; Clinical Trials as Topic; Conduct Disorder; Diagnosis, Differential; Humans; Magnetic Resonance Imaging; Methylphenidate; Nerve Net; Neuroimaging; Neuroprotective Agents; Positron-Emission Tomography; White Matter | 2014 |
The pharmacological management of oppositional behaviour, conduct problems, and aggression in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder: a systematic review and meta-analysi
Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Adrenergic Uptake Inhibitors; Aggression; Atomoxetine Hydrochloride; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Conduct Disorder; Humans | 2015 |
Attention-deficit-hyperactivity disorder: an update.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Amphetamine; Antidepressive Agents, Second-Generation; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bupropion; Case-Control Studies; Central Nervous System Stimulants; Child; Conduct Disorder; Follow-Up Studies; Humans; Juvenile Delinquency; Longitudinal Studies; Methylphenidate; Patient Compliance; Prescriptions; Prevalence; Propylamines; Substance-Related Disorders; Time Factors; Treatment Outcome; United States | 2009 |
2 trial(s) available for atomoxetine hydrochloride and Callous-Unemotional Traits
| Article | Year |
|---|---|
Effect of atomoxetine on quality of life and family burden: results from a randomized, placebo-controlled, double-blind study in children and adolescents with ADHD and comorbid oppositional defiant or conduct disorder.
Topics: Adaptation, Psychological; Adolescent; Adolescent Behavior; Adrenergic Uptake Inhibitors; Analysis of Variance; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Child Welfare; Conduct Disorder; Confidence Intervals; Double-Blind Method; Family Relations; Female; Humans; Male; Propylamines; Psychometrics; Self Concept; Stress, Psychological; Students, Medical; Surveys and Questionnaires | 2011 |
Atomoxetine versus placebo in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: a double-blind, randomized, multicenter trial in Germany.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Child; Comorbidity; Conduct Disorder; Disease Progression; Double-Blind Method; Female; Germany; Humans; Male; Placebos; Propylamines; Treatment Outcome | 2011 |
3 other study(ies) available for atomoxetine hydrochloride and Callous-Unemotional Traits
| Article | Year |
|---|---|
Effective use of atomoxetine to treat six inpatient youths with disruptive mood dysregulation disorder without attention deficit disorder.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Aggression; Atomoxetine Hydrochloride; Attention; Child; Conduct Disorder; Drug Tolerance; Female; Humans; Male | 2020 |
Does Comorbid Disruptive Behavior Modify the Effects of Atomoxetine on ADHD Symptoms as Measured by a Continuous Performance Test and a Motion Tracking Device?
Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Comorbidity; Conduct Disorder; Double-Blind Method; Female; Humans; Male; Personality Assessment; Propylamines; Quality of Life; Reaction Time; Treatment Outcome | 2015 |
Psychopharmacologic treatment of attention-deficit/hyperactivity disorder and disruptive behavior disorders.
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Atomoxetine Hydrochloride; Attention Deficit and Disruptive Behavior Disorders; Benzhydryl Compounds; Central Nervous System Stimulants; Conduct Disorder; Humans; Modafinil; Neurobiology; Pediatrics; Propylamines; Psychopharmacology; Selective Serotonin Reuptake Inhibitors; United States | 2007 |